Candel Therapeutics, Inc.(CADL), a clinical-stage biopharmaceutical company, on Monday announced the appointment of Charles Schoch as Chief Financial Officer, with an immediate effect.
Schoch joined the company in Novemeber 2021 and has served as interim CFO since January 2024, will now transition to the CFO role permanently.
Prior to joining Candel, Schoch served as Corporate Controller at Corbus Pharmaceuticals since 2019.
On Friday, Candel closed trading 3.46% lesser at $4.75 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.